AIG
HRTX icon

American International Group’s Heron Therapeutics HRTX Stock Holding History

American International Group’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,029
Closed -$141K – 1226
2024
Q1 		$141K Sell
51,029
-438
-0.9% -$1.1K ﹤0.01% 2333
2023
Q4 		$87.5K Sell
51,467
-208
-0.4% -$229 ﹤0.01% 2631
2023
Q3 		$53.2K Buy
51,675
+1,837
+4% +$2.61K ﹤0.01% 2800
2023
Q2 		$57.8K Buy
49,838
+168
+0.3% +$300 ﹤0.01% 2842
2023
Q1 		$75K Buy
49,670
+989
+2% +$2.48K ﹤0.01% 2583
2022
Q4 		$122K Sell
48,681
-177
-0.4% -$570 ﹤0.01% 2417
2022
Q3 		$206K Buy
48,858
+690
+1% +$2.7K ﹤0.01% 2139
2022
Q2 		$134K Buy
48,168
+2,299
+5% +$9.23K ﹤0.01% 2422
2022
Q1 		$262K Sell
45,869
-3,228
-7% -$23.6K ﹤0.01% 2089
2021
Q4 		$448K Sell
49,097
-1,470
-3% -$15K ﹤0.01% 1894
2021
Q3 		$541K Sell
50,567
-1,201
-2% -$14.6K ﹤0.01% 1799
2021
Q2 		$803 Buy
51,768
+694
+1% +$11K ﹤0.01% 1627
2021
Q1 		$828 Buy
51,074
+136
+0.3% +$2.42K ﹤0.01% 1562
2020
Q4 		$1.08K Sell
50,938
-1,462
-3% -$25.4K ﹤0.01% 1334
2020
Q3 		$777K Sell
52,400
-1,192
-2% -$18.6K ﹤0.01% 1367
2020
Q2 		$788K Buy
53,592
+3,833
+8% +$63K ﹤0.01% 1349
2020
Q1 		$584K Sell
49,759
-2,875
-5% -$54K ﹤0.01% 1356
2019
Q4 		$1.24M Buy
52,634
+6,030
+13% +$133K ﹤0.01% 1226
2019
Q3 		$862K Sell
46,604
-325
-0.7% -$5.98K ﹤0.01% 1370
2019
Q2 		$872K Buy
46,929
+2,973
+7% +$59.4K ﹤0.01% 1392
2019
Q1 		$1.07M Sell
43,956
-1,425
-3% -$37.3K ﹤0.01% 1281
2018
Q4 		$1.18M Sell
45,381
-350
-0.8% -$9.62K ﹤0.01% 1181
2018
Q3 		$1.45M Buy
45,731
+4,166
+10% +$155K ﹤0.01% 1219
2018
Q2 		$1.61M Buy
41,565
+6,856
+20% +$218K 0.01% 1105
2018
Q1 		$958K Buy
34,709
+4,107
+13% +$93.2K ﹤0.01% 1294
2017
Q4 		$554K Buy
30,602
+145
+0.5% +$2.36K ﹤0.01% 1731
2017
Q3 		$492K Buy
30,457
+2,277
+8% +$35.7K ﹤0.01% 1776
2017
Q2 		$390K Buy
28,180
+2,848
+11% +$41.3K ﹤0.01% 1869
2017
Q1 		$380K Buy
25,332
+7,059
+39% +$97.7K ﹤0.01% 1786
2016
Q4 		$239K Sell
18,273
-48
-0.3% -$753 ﹤0.01% 2075
2016
Q3 		$316K Buy
18,321
+28
+0.2% +$520 ﹤0.01% 1879
2016
Q2 		$330K Buy
18,293
+1,369
+8% +$26.7K ﹤0.01% 1816
2016
Q1 		$321K Buy
16,924
+2,489
+17% +$49.1K ﹤0.01% 2359
2015
Q4 		$385K Sell
14,435
-25
-0.2% -$669 ﹤0.01% 2247
2015
Q3 		$353K Buy
14,460
+17
+0.1% +$567 ﹤0.01% 2318
2015
Q2 		$450K Sell
14,443
-203
-1% -$3.82K ﹤0.01% 2283
2015
Q1 		$213K Hold
14,646
– – ﹤0.01% 2895
2014
Q4 		$147K Buy
14,646
+1,886
+15% +$15.4K ﹤0.01% 3222
2014
Q3 		$106K Sell
12,760
-472
-4% -$4.39K ﹤0.01% 3495
2014
Q2 		$163K Buy
13,232
+13,112
+10,927% +$157K ﹤0.01% 3170
2014
Q1 		$1.67K Buy
+120
New +$1.6K ﹤0.01% 4706

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

American International Group's HRTX Position: Q2 2024 in Review

American International Group sold out of Heron Therapeutics (HRTX) in Q2 2024, closing a stake of 51,029 shares — an estimated $141K sold.

American International Group first reported a position in HRTX in Q1 2014 and held it in 41 quarters. The position peaked at $1.61M in Q2 2018. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2024.

  • American International Group reported no remaining Heron Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 51,029 Heron Therapeutics shares in Q2 2024, an estimated $141K.
  • American International Group first reported a position in Heron Therapeutics in Q1 2014 and held it in 41 quarters.
  • American International Group's Heron Therapeutics position peaked at $1.61M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.